Alpha Teknova (NASDAQ:TKNO) Trading Down 11%

Alpha Teknova, Inc. (NASDAQ:TKNOGet Free Report)’s stock price fell 11% during trading on Tuesday . The stock traded as low as $2.41 and last traded at $2.50. 118,217 shares were traded during trading, an increase of 702% from the average session volume of 14,735 shares. The stock had previously closed at $2.81.

Analyst Ratings Changes

Separately, BTIG Research cut shares of Alpha Teknova from a “buy” rating to a “neutral” rating in a research report on Tuesday, March 12th.

Check Out Our Latest Research Report on TKNO

Alpha Teknova Stock Performance

The business has a fifty day moving average of $3.01 and a 200 day moving average of $2.75. The company has a market cap of $102.05 million, a P/E ratio of -2.16 and a beta of 0.23. The company has a quick ratio of 3.84, a current ratio of 5.14 and a debt-to-equity ratio of 0.15.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in TKNO. JPMorgan Chase & Co. raised its stake in shares of Alpha Teknova by 27.9% in the first quarter. JPMorgan Chase & Co. now owns 6,571 shares of the company’s stock valued at $91,000 after acquiring an additional 1,435 shares during the period. State Street Corp raised its holdings in shares of Alpha Teknova by 10.3% in the first quarter. State Street Corp now owns 117,596 shares of the company’s stock valued at $1,624,000 after acquiring an additional 11,012 shares in the last quarter. Wellington Management Group LLP lifted its stake in Alpha Teknova by 27.7% in the first quarter. Wellington Management Group LLP now owns 1,333,638 shares of the company’s stock worth $18,418,000 after acquiring an additional 289,433 shares during the period. Goldman Sachs Group Inc. bought a new position in Alpha Teknova during the 1st quarter worth about $145,000. Finally, Sei Investments Co. bought a new position in Alpha Teknova during the 2nd quarter worth about $175,000. 13.81% of the stock is owned by hedge funds and other institutional investors.

About Alpha Teknova

(Get Free Report)

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

Read More

Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.